|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 14 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
50,900 |
229,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-06-04 |
4 |
S |
$62.52 |
$62,521 |
D/D |
(1,000) |
178,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-08-20 |
4 |
AS |
$70.00 |
$350,000 |
I/I |
(5,000) |
46,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-08-20 |
4 |
OE |
$12.99 |
$64,950 |
I/I |
5,000 |
51,195 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2014-09-29 |
4 |
D |
$74.00 |
$630,850 |
D/D |
(8,525) |
1,200 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2014-09-29 |
4 |
D |
$74.00 |
$88,800 |
D/D |
(1,200) |
0 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-10-08 |
4 |
B |
$17.50 |
$75,005 |
D/D |
4,286 |
25,119 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-21 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
48,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-21 |
4 |
AS |
$75.00 |
$150,000 |
I/I |
(2,000) |
46,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-24 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
48,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-24 |
4 |
AS |
$80.00 |
$160,000 |
I/I |
(2,000) |
46,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-03 |
4 |
S |
$85.33 |
$256,002 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-10 |
4 |
S |
$87.00 |
$348,000 |
I/I |
(4,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-10 |
4 |
OE |
$12.99 |
$51,960 |
I/I |
4,000 |
47,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-12 |
4 |
S |
$81.51 |
$81,513 |
D/D |
(1,000) |
228,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-25 |
4 |
AS |
$90.00 |
$180,000 |
I/I |
(2,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-25 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
45,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-10 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
45,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-10 |
4 |
AS |
$95.00 |
$190,000 |
I/I |
(2,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-24 |
4 |
AS |
$88.73 |
$177,462 |
D/D |
(2,000) |
227,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-24 |
4 |
AS |
$88.73 |
$266,193 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-24 |
4 |
OE |
$12.99 |
$38,970 |
I/I |
3,000 |
46,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-01-09 |
4 |
AS |
$94.14 |
$188,286 |
D/D |
(2,000) |
225,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-02 |
4 |
AS |
$107.96 |
$323,893 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-02 |
4 |
AS |
$108.44 |
$542,195 |
D/D |
(5,000) |
220,157 |
0 |
- |
|
850 Records found
|
|
Page 14 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|